InnoCore Pharmaceuticals Revenue and Competitors

InnoCore specializes in the formulation, process development, and manufacturing of long acting and minimally invasive injectable drug delivery products. \n\n\nInnoCore offers a unique and highly tunable polymer platform to control the delivery drug compounds, including small molecules (e.g. peptides and low solubles) and biologics (e.g. proteins and antibodies). \n\nOur proprietary polymer platform features a variety of benefits to your API's such as:\n- solving toxicity challenges\n- maintaining/increasing stability and structural integrity of sensitive compounds (e.g. by applying low temperature process conditions during manufacturing)\n- sustained release of of drug molecules from days up to at least 6 months\n- precise control over particle size (preventing absorption by macrophages and ensuring injectability)\n- ensuring smooth bioavailability\n- enabling the use of small needle sizes for patient compliance\n\nBy merging developmental collaborations and licensing partnerships with our exclusive SynBiosys biodegradable polymer technologies, we generate innovative injectable and implantable drug delivery products. \n\nWe invite you to navigate through our website and discover how we can enhance the performance of your device and/or drug and add value to your product pipeline.